Akèy › Maladi fwa steatotik › Connecticut
Etid klinik pou Maladi fwa steatotik nan Connecticut
5 etid pou Maladi fwa steatotik ap chèche patisipan nan sit nan Connecticut.
Vil nan Connecticut
Tèks ofisyèl etid la (Anglè)
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Medical Research Center of Connecticut, Hamden
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, New Haven
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06528314Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
- Yale New Haven Hospital, New Haven
Ap rekriteEtid obsèvasyon
Laj 12 a 18 · Tout sèks · Mizajou Jul 30, 2026 · NCT04634643Reversal of Lipid-Induced Insulin Resistance
- Yale Center for Clinical Investigation HRU, New Haven
Ap rekriteVolontè an sante akeyi
Laj 18 a 90 · Tout sèks · Mizajou Jun 22, 2026 · NCT02193295Digoxin In NASH (CODIN)
- Yale New Haven Health, New Haven
- Yale New Haven Hospital, New Haven
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou May 26, 2026 · NCT06588699Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.